Martin Buysschaert

Summary

Country: Belgium

Publications

  1. doi request reprint One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
    M Buysschaert
    Department of Endocrinology and Diabetology, Saint Luc Academic Hospital, Cliniques Universitaires Saint Luc, Universite Catholique de Louvain, Avenue Hippocrate 54 UCL 5474, B 1200 Brussels, Belgium
    Diabetes Metab 36:381-8. 2010
  2. doi request reprint Definition of prediabetes
    Martin Buysschaert
    Department of Endocrinology and Diabetology, University Clinic Saint Luc, Universite Catholique de Louvain UCL, Avenue Hippocrate 54 UCL 5474, B 1200 Brussels, Belgium
    Med Clin North Am 95:289-97, vii. 2011
  3. ncbi request reprint Glycemic control and weight changes in patients with type 2 diabetes intensified to three insulin regimens after therapeutic failure to exenatide
    M Buysschaert
    Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Service d endocrinologie et nutrition
    Acta Clin Belg 67:250-4. 2012
  4. doi request reprint ROOTS: A multicenter study in Belgium to evaluate the effectiveness and safety of liraglutide (Victoza®) in type 2 diabetic patients
    Martin Buysschaert
    Department of Endocrinology and Diabetology, Universite Catholique de Louvain, University Clinic St Luc, Brussels, Belgium Electronic address
    Diabetes Metab Syndr 9:139-42. 2015
  5. ncbi request reprint Definitions (and Current Controversies) of Diabetes and Prediabetes
    Martin Buysschaert
    Service d endocrinologie et nutrition, Cliniques Universitaires St Luc, Universite Catholique de Louvain, Brussels, Belgium
    Curr Diabetes Rev 12:8-13. 2016
  6. doi request reprint Diabetes and cancer: a 2013 synopsis
    M Buysschaert
    Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Avenue Hippocrate 54 UCL 5474, B 1200 Bruxelles, Belgium Electronic address
    Diabetes Metab Syndr 7:247-50. 2013
  7. doi request reprint Improvement of psoriasis during exenatide treatment in a patient with diabetes
    M Buysschaert
    Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Service d endocrinologie et nutrition, Avenue Hippocrate 54 UCL 5474, 1200 Bruxelles, Belgium
    Diabetes Metab 38:86-8. 2012
  8. ncbi request reprint Hemiballism revealing type 2 diabetes in an elderly: clinical and neuroimaging findings and etiopathogenic links
    M Buysschaert
    Departement d Endocrinologie et Nutrition, Cliniques Universitaires UCL Saint Luc, Brussels, Belgium
    Acta Clin Belg 66:387-9. 2011
  9. ncbi request reprint Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation
    Vanessa Preumont
    Department of Endocrinology and Nutrition, Universite Catholique de Louvain, Cliniques Universitaires St Luc, Brussels, Belgium
    Diabetes Care 30:1187-92. 2007
  10. doi request reprint Prediabetes and associated disorders
    Martin Buysschaert
    Department of Endocrinology and Diabetology, University Clinic Saint Luc, Universite Catholique de Louvain, Brussels, Belgium
    Endocrine 48:371-93. 2015

Collaborators

Detail Information

Publications13

  1. doi request reprint One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
    M Buysschaert
    Department of Endocrinology and Diabetology, Saint Luc Academic Hospital, Cliniques Universitaires Saint Luc, Universite Catholique de Louvain, Avenue Hippocrate 54 UCL 5474, B 1200 Brussels, Belgium
    Diabetes Metab 36:381-8. 2010
    ..The study objective was to analyze, in everyday practice, the long-term metabolic effects of exenatide (for 9 and 12 months) in patients with type 2 diabetes not responding to treatments with metformin and sulphonylurea at maximum dosages...
  2. doi request reprint Definition of prediabetes
    Martin Buysschaert
    Department of Endocrinology and Diabetology, University Clinic Saint Luc, Universite Catholique de Louvain UCL, Avenue Hippocrate 54 UCL 5474, B 1200 Brussels, Belgium
    Med Clin North Am 95:289-97, vii. 2011
    ..Therefore, an absolute definition of prediabetes may underestimate the implications and vastness of this disorder. Research should focus on these aspects to minimize the risk of developing a preventable condition...
  3. ncbi request reprint Glycemic control and weight changes in patients with type 2 diabetes intensified to three insulin regimens after therapeutic failure to exenatide
    M Buysschaert
    Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Service d endocrinologie et nutrition
    Acta Clin Belg 67:250-4. 2012
    ..0001). In conclusion, a high proportion of patients remained above the HbA(1c) targets after 6-12 month's treatment, despite a progressive increase in insulin dosages. Insulin treatment was associated with a marked weight gain...
  4. doi request reprint ROOTS: A multicenter study in Belgium to evaluate the effectiveness and safety of liraglutide (Victoza®) in type 2 diabetic patients
    Martin Buysschaert
    Department of Endocrinology and Diabetology, Universite Catholique de Louvain, University Clinic St Luc, Brussels, Belgium Electronic address
    Diabetes Metab Syndr 9:139-42. 2015
    ..The primary endpoint was to estimate the proportion of patients achieving improved glycaemic control defined as a HbA1c<7% or with a decrease of ≥1% after 12 months...
  5. ncbi request reprint Definitions (and Current Controversies) of Diabetes and Prediabetes
    Martin Buysschaert
    Service d endocrinologie et nutrition, Cliniques Universitaires St Luc, Universite Catholique de Louvain, Brussels, Belgium
    Curr Diabetes Rev 12:8-13. 2016
    ..7 - 6.4%, with however some potential discordance between tests. The threshold of fasting plasma glucose defining Impaired Fasting Glucose as well as the adequacy of HbA1c as a correct diagnostic tool for prediabetes is still debated. ..
  6. doi request reprint Diabetes and cancer: a 2013 synopsis
    M Buysschaert
    Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Avenue Hippocrate 54 UCL 5474, B 1200 Bruxelles, Belgium Electronic address
    Diabetes Metab Syndr 7:247-50. 2013
    ..Considering all these data together, cancer should be considered as a "new potential complication" of diabetes and integrated in the follow-up of diabetic subjects. ..
  7. doi request reprint Improvement of psoriasis during exenatide treatment in a patient with diabetes
    M Buysschaert
    Universite Catholique de Louvain, Cliniques Universitaires Saint Luc, Service d endocrinologie et nutrition, Avenue Hippocrate 54 UCL 5474, 1200 Bruxelles, Belgium
    Diabetes Metab 38:86-8. 2012
    ..This report is of a clinically significant improvement in psoriasis lesions in a patient with T2D during treatment with a GLP-1 receptor agonist (exenatide)...
  8. ncbi request reprint Hemiballism revealing type 2 diabetes in an elderly: clinical and neuroimaging findings and etiopathogenic links
    M Buysschaert
    Departement d Endocrinologie et Nutrition, Cliniques Universitaires UCL Saint Luc, Brussels, Belgium
    Acta Clin Belg 66:387-9. 2011
    ..We hereby describe clinical and neuroimaging findings. After initiation of treatment and restoration of euglycaemia, we note a complete remission of the initial neurological symptoms...
  9. ncbi request reprint Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation
    Vanessa Preumont
    Department of Endocrinology and Nutrition, Universite Catholique de Louvain, Cliniques Universitaires St Luc, Brussels, Belgium
    Diabetes Care 30:1187-92. 2007
    ....
  10. doi request reprint Prediabetes and associated disorders
    Martin Buysschaert
    Department of Endocrinology and Diabetology, University Clinic Saint Luc, Universite Catholique de Louvain, Brussels, Belgium
    Endocrine 48:371-93. 2015
    ....
  11. doi request reprint Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels
    Laurent Querton
    Service d endocrinologie et nutrition, Cliniques Universitaires St Luc, Universite Catholique de Louvain, Avenue Hippocrate UCL 54 74 B 1200 Brussels, Belgium
    J Clin Lipidol 6:434-42. 2012
    ..Because substantial residual risk persists at LDL-C <70 mg/dL, a more comprehensive control of non-LDL-C and particles was recommended in the joint 2008 American Diabetes Association/American College of Cardiology Consensus...
  12. ncbi request reprint Solitary pancreas transplantation for life-threatening allergy to human insulin
    Jacqueline Léonet
    Department of Diabetology, Centre Medical Amercoeur, Universite Catholique de Louvain, Brussels, Belgium
    Transpl Int 19:474-7. 2006
    ..Allergic manifestations reappeared promptly. Currently, 2 years after transplantation, the patient is euglycaemic without insulin (glycated haemoglobin 5.8%) and he is free of allergic reactions...
  13. doi request reprint What are the characteristics of phenotypic type 2 diabetic patients with low-titer GAD65 antibodies?
    Yovan P Mahadeb
    Service d endocrinologie et nutrition, Cliniques Universitaires St Luc, Universite Catholique de Louvain, Avenue Hippocrate UCL 54 74, 1200, Brussels, Belgium
    Acta Diabetol 51:103-11. 2014
    ....